Brazil signs vaccine deal with Indian company

Tribune Web Desk

Updated At : 02:42 PM Feb 26, 2021 IST

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits

Yearly Premium ₹999 ₹349/Year

Yearly Premium $49 $24.99/Year

Sao Paulo, February 26

On the same day Brazil reached the grim milestone of 250,000 deaths by Covid, the country’s health ministry signed a deal with Indian pharmaceutical company Bharat Biotech for the purchase of 20 million doses of the Covaxin vaccine, which is yet to be approved by local regulators.

The administration of President Jair Bolsonaro said the first 8 million Covaxin shots, which would be made by Brazilian company Precisa Medicamentos, would arrive in March. A second batch of another eight million doses is expected for April and in May, another four million doses will be available.

So far Brazil has vaccinated less than 4 per cent of its population of 210 million people, with some cities stopping immunisation campaigns last week due to shortages.

Neither Precisa nor Bharat confirmed the deal or the delivery dates. AP

The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist, and is run by a trust comprising five eminent persons as trustees.

The Tribune, the largest selling English daily in North India, publishes news and views without any bias or prejudice of any kind. Restraint and moderation, rather than agitational language and partisanship, are the hallmarks of the newspaper. It is an independent newspaper in the real sense of the term.

The Tribune has two sister publications, Punjabi Tribune (in Punjabi) and Dainik Tribune (in Hindi).

Remembering Sardar Dyal Singh Majithia

Designed and developed by : SORTD

Unlock Exclusive Insights with The Tribune Premium

Suggested Articles